glp 1 risk GLP-1s may reduce cancer for adults with obesity GI Adverse Effects of Glucagon-Like

Lawsuits allege that some doctors encouraged off-label use of these medications for weight loss patients without providing adequate warnings about possible side effects like delayed gastric emptying, severe gastroparesis, and sudden vision loss

The clinical trial study is slated to run until November of 2027

Book Now No referral needed Most insurance accepted Chesapeake, VA

The primary outcome of this study was the first diagnosis of CRC within 15 years from the initial treatment of GLP-1RAs or non-GLP-1RA diabetes medications (insulin, metformin, alpha-glucosidase inhibitors, dipeptidyl-peptidase-4 inhibitors (DPP-4i), sodium-glucose cotransporter-2 inhibitors (SGLT2i), sulfonylureas (SU), and thiazolidinediones (TZD))